Corpus Intelligence IC Memo — MEMORIAL HEALTH CARE SYSTEM INC. 2026-04-26 09:55 UTC
IC Memo — MEMORIAL HEALTH CARE SYSTEM INC.
Investment Committee Memorandum | TN | 431 beds | Grade B | EBITDA uplift $43.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MEMORIAL HEALTH CARE SYSTEM INC.

CCN 440091 | nan, TN | 431 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

MEMORIAL HEALTH CARE SYSTEM INC. is a 431-bed suburban community hospital in nan, TN with $583.9M in net patient revenue and a -9.0% operating margin. The hospital serves a payer mix of 31.9% Medicare, 1.1% Medicaid, and 66.9% commercial.

Thesis: Undervalued. Our ML models identify $43.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -9.0% to -1.6% (+736bps).

Net Revenue HCRIS$583.9M
Current EBITDA COMPUTED$-52.3M
Operating Margin COMPUTED-9.0%
Occupancy HCRIS64.3%
Revenue / Bed COMPUTED$1.4M
Net-to-Gross HCRIS21.1%
Distress Probability ML44.2%

2. Market Context & Competitive Position

141
TN Hospitals
-0.6%
State Median Margin
20
Comparable Hospitals

TN has 141 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of -9.0% places it below the state median. Among 20 size-comparable peers (216-862 beds), the median margin is -2.6%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (216-862), prioritizing same-state peers. 20 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MEMORIAL HEALTH CARE SYSTEM IN (Target)TN431$583.9M-9.0%
ERLANGER MEDICAL CENTERTN750$1.09B-6.4%
UNIVERSITY OF TENNESSEE MEDICATN698$1.08B-17.6%
SAINT THOMAS WEST HOSPITALTN643$1.06B0.2%
TRISTAR CENTENNIAL MEDICAL CENTN598$991.8M23.0%
JACKSON-MADISON COUNTY GENERALTN580$797.1M1.4%
BAPTIST MEM HOSPITAL MEMPHISTN800$766.1M-12.7%
JOHNSON CITY MEDICAL CENTERTN537$546.1M-8.6%
SAINT THOMAS RUTHERFORD HOSPITTN354$447.4M1.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $43.0M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$12.3M+210bp18mo
Cost to Collect4.5%2.5%$11.7M+200bp12mo
Denial Rate Reduction12.0%6.5%$11.6M+198bp12mo
A/R Days Reduction5200.0%3800.0%$7.1M+122bp9mo
Clean Claim Rate88.0%96.0%$374K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$12.3M
Cost to Collect
$11.7M
Denial Rate Reduction
$11.6M
A/R Days Reduction
$7.1M
Clean Claim Rate
$374K
Total EBITDA Uplift$43.0M
Current EBITDA$-52.3M
+ RCM Uplift+$43.0M
Pro Forma EBITDA$-9.4M
Current Margin-9.0%
Pro Forma Margin-1.6%
WC Released (1x)$22.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-80.5M$84.5M0.00x-100.0%
Base (11x exit)10.0x11.0x$-80.5M$66.8M0.00x-100.0%
Bull Case9.0x11.0x$-72.5M$182.5M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-72.5M$177.7M0.00x-100.0%
Bear Case11.0x10.0x$-88.6M$-104.2M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-88.6M$-143.4M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 20 hospitals with 216-862 beds
  • Same-state prioritization (n=21)
  • Comp margins: P25=-9.5% / P50=-2.6% / P75=7.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.